- Asthma and respiratory diseases
- Respiratory and Cough-Related Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms
- Context-Aware Activity Recognition Systems
- Non-Invasive Vital Sign Monitoring
- Chronic Disease Management Strategies
- Voice and Speech Disorders
- School Health and Nursing Education
- Healthcare cost, quality, practices
- Allergic Rhinitis and Sensitization
- Inhalation and Respiratory Drug Delivery
Curtin University
2024-2025
Sir Charles Gairdner Hospital
2022-2025
Institute for Respiratory Health
2024
The University of Western Australia
2024
Asthma is a common and complex syndrome, major cause of morbidity healthcare costs. Clinicians have an array evidence-based investigations effective interventions at their disposal, but outcomes not improved as much trial evidence would suggest they could. This article discusses drivers behind this discrepancy using illustrative examples to highlight information gaps barriers that impair the delivery community emergency asthma care appropriate referral specialist services. It highlights...
Spirometry remains the gold standard to diagnose and monitor respiratory disease [1]. However, limited access has been further exacerbated by restrictions introduced during COVID-19 pandemic. Underutilisation of objective testing with spirometry contributes misdiagnosis diseases such as asthma chronic obstructive pulmonary (COPD) [2, 3]. Home is accurate in patients relatively normal lung function may overcome some access, cost, infection control barriers associated in-clinic [4–8]. What...
Abstract A young woman with historically mild asthma experienced worsening breathlessness and cough competitive ice skating. Despite optimizing escalating treatment for her eosinophilic asthma, addressing known exacerbating factors, symptoms remained uncontrolled refractory to bronchodilators oral corticosteroids. Objective testing suggested presentation was out of keeping alone, she suspected have comorbid dysfunctional breathing and/or inducible laryngeal obstruction. Evidence required...
Abstract Asthma is a highly prevalent but heterogenous condition. Uncontrolled disease relatively common and may be due to ongoing inflammation and/or persisting bronchial hyper‐reactivity. Bronchial thermoplasty has been in use for many years optimal case selection post‐procedure assessment remain uncertain. We present of gentleman his 50s with lifelong asthma who experienced persistent loss control following influenza A 2017. Despite multidisciplinary guideline‐based escalation therapy, he...